Trinity Biotech | TRIB - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Abbott USD 1.74B 23.39B 2025-09
Bayer EUR 982.42M 0 2025-12
Bio-Rad Laboratories USD 26.99M 18K 2025-12
EDAP TMS EUR 37.39M 0 2025-09
J&J USD 2.41B 1.74M 2025-12
Mesa Laboratories USD 349.53M 3.53M 2024-09
OraSure Technologies USD 70.39M 1.87M 2025-12
Plus Therapeutics USD 138.68M 7.07M 2025-12
Roche Holding CHF 795.62M 699.54K 2025-12
Siemens EUR 780.74M 6.33M 2025-12
Thermo Fisher Scientific USD 371.62M 4.09M 2026-03
Tosoh JPY 307.89M 2.47M 2026-03
Trinity Biotech USD 386.76M 1.57M 2025-12
Veracyte USD 79.79M 743K 2026-03